Spiro [11H-lmidazo[2,1-b][3]benzazepine-11,4’-piperadine compound and pharmaceutical composition thereof

PK139931AUndetermined Publication Date: 2009-01-22JANSSEN PHARMA NV
0 Cites 0 Cited by

Patent Information

Application Number
PK199901066
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-22
Patent Text Reader

Abstract

This invention concerns the compound of formula a prodrug, a N-oxide, a quaternary amine or a stereochemically isomeric form thereof whereinR¹ is hydrogen, C1-6 alkyl, halo, formyl, carboxyl, C1-6 alkyloxycarbonyl, (C)1-6alkylcarbonyl, N(R³R⁴)C(=O)-, N(R³R⁴)C(=O)N(R⁵) ethenyl substituted with carboxyl or C1-6 alkyloxycarbonyl, or Chalky! substituted with hydroxy, carboxyl, C1-6 alkyloxy, C1-6 alkyloxycarbonyl, N(R³R⁴)C(=O)-, C1-6 alkylC(=O)NR⁵)-, C1-6 alkylS(=O)₂NR₅)- or N(R3R4)C(=O)NR5)- wherein each R3 and each R4 independently are hydrogen or C1-4alkyl, and R5 is hydrogen or hydroxy; R2 is hydrogen, Chalky!, hydroxyC1-6alkyl, C1-6alkyloxyC16alkyl, N(R3R4)C(=O)-, aryl or halo; n is 1 or 2; A-B- represents a bivalent radical of formula -Y-CH=CH-, -CH=CH-Y-, or -CH=CH-CH=CH-, wherein each hydrogen atom may independently be replaced by R6 wherein R is Chalkyl, halo, hydroxy, C1-6alkyloxy, ethenyl substituted with carboxyl or C1-6alkyloxycarbonyl, hydroxyC16alkyl, formyl, carboxyl or hydroxycarbonylC16alkyl, and each Y independently is a bivalent radical of formula -O-, -S- or –NR7-, wherein R7 is hydrogen, Chalkyl or C1-6alkylcarbonyl; Z is is a bivalent radical of formula -(CH2)p-, -CH=CH-, CH2-CHOH-, -CH2-O-, -CH2-C(=O), or -CH2-C(=NOH)-, provided that the bivalent radicals are connected to the nitrogen of the imidazole ring via their -CH2- moiety; and wherein p is 1, 2, 3 or 4; Lis hydrogen; C1-6alkyl; C2.6alkenyl; Calkylcarbonyl; C16alkyloxycarbonyl; C1-6alkyl substituted with hydroxy, carboxyl, C1.6alkyloxy, C1.6alkyloxycarbonyl, aryl, aryloxy, cyano or R8HN- wherein R8 is hydrogen, C1-6alkyl, C16alkyloxycarbonyl, C1-6alkylcarbonyl; or L represents a radical of formula -Alk-Y-Het1, Alk-NH-CO-Het2 or -Alk-Het3 wherein Alk represents C1_4alkanediyl; Y represents O, S or NH ; Het1, Het2 and each represent an optionally substituted heterocycle; for use as a medicine.
Need to check novelty before this filing date? Find Prior Art